Zecong Xiao

11PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 15, 2025
αPD-1-conjugated acid-cleavable nanodrugs overcomes cellular immunotherapy barriers in pancreatic tumors.

Ziqi Gan, Jing Huang, Shuting Duan

|Apr 02, 2024
Light-inducible nanodrug-mediated photodynamic and anti-apoptotic synergy for enhanced immunotherapy in triple-negative breast cancer.

Jing Huang, Xingliang Liu, Minzhao Lin

|Oct 17, 2023
Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.

Ye Chen, Jiaxin Bei, Meijuan Chen

|Sep 23, 2023
Nanodrug regulates ROS homeostasis via enhancing fatty acid oxidation and inhibiting autophagy to overcome tumor drug resistance.

HaiYang Wang, Minzhao Lin, Gengjia Chen

|May 23, 2023
Nanodrug Augmenting Antitumor Immunity for Enhanced TNBC Therapy via Pyroptosis and cGAS-STING Activation.

Huihai Zhong, Gengjia Chen, Tan Li

|Jul 07, 2022
Nanodrugs Incorporating LDHA siRNA Inhibit M2-like Polarization of TAMs and Amplify Autophagy to Assist Oxaliplatin Chemotherapy against Colorectal Cancer.

Lijun Hu, Sicong Huang, Gengjia Chen

Pageof 2

Frequent Collaborators

10 joint publications

Xintao Shuai

2 joint publications

Jinsheng Huang

1 joint publications

Yu-Jun Cai

1 joint publications

Zhenwei Su